News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
349,825 Results
Type
Article (21352)
Company Profile (141)
Press Release (328318)
Multimedia
Podcasts (112)
Webinars (17)
Section
Business (106914)
Career Advice (893)
Deals (18826)
Drug Delivery (110)
Drug Development (51460)
Employer Resources (80)
FDA (7971)
Job Trends (7906)
News (188639)
Policy (17638)
Tag
2027 Genetown Elite (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (2)
Academia (782)
Accelerated approval (19)
Adcomms (23)
Allergies (83)
Alliances (28237)
ALS (92)
Alzheimer's disease (825)
Antibody-drug conjugate (ADC) (208)
Approvals (8156)
Artificial intelligence (284)
Autoimmune disease (86)
Automation (15)
Bankruptcy (181)
Best Places to Work (5625)
BIOSECURE Act (14)
Biosimilars (172)
Biotechnology (60)
Bladder cancer (74)
Brain cancer (35)
Breast cancer (268)
Cancer (2329)
Cardiovascular disease (245)
Career advice (742)
Career pathing (24)
CAR-T (111)
CDC (14)
Cell therapy (289)
Cervical cancer (11)
Clinical research (45151)
Collaboration (1021)
Company closure (1)
Compensation (389)
Complete response letters (53)
COVID-19 (1177)
CRISPR (51)
C-suite (535)
Cystic fibrosis (89)
Data (3352)
Decentralized trials (2)
Denatured (27)
Depression (83)
Diabetes (259)
Diagnostics (1947)
Digital health (16)
Diversity (9)
Diversity, equity & inclusion (22)
Drug discovery (171)
Drug pricing (200)
Drug shortages (33)
Duchenne muscular dystrophy (138)
Earnings (41157)
Editorial (46)
Employer branding (10)
Employer resources (78)
Events (51648)
Executive appointments (622)
FDA (9581)
Fibrodysplasia Ossificans Progressiva (4)
Friedreich's ataxia (3)
Frontotemporal dementia (5)
Funding (665)
Gene editing (93)
Generative AI (32)
Gene therapy (276)
GLP-1 (825)
Government (2057)
Grass and pollen (4)
Guidances (205)
Healthcare (6117)
HIV (29)
Huntington's disease (24)
IgA nephropathy (60)
Immunology and inflammation (169)
Immuno-oncology (35)
Indications (68)
Infectious disease (1313)
Inflammatory bowel disease (121)
Inflation Reduction Act (12)
Influenza (48)
Intellectual property (137)
Interviews (118)
IPO (7491)
IRA (53)
Job creations (2455)
Job search strategy (654)
JPM (52)
Kidney cancer (10)
Labor market (61)
Layoffs (344)
Leadership (27)
Legal (4188)
Liver cancer (37)
Longevity (8)
Lung cancer (335)
Lymphoma (209)
Machine learning (21)
Management (31)
Manufacturing (529)
MASH (104)
Medical device (2189)
Medtech (2197)
Mergers & acquisitions (11874)
Metabolic disorders (898)
Multiple sclerosis (110)
NASH (20)
Neurodegenerative disease (166)
Neuropsychiatric disorders (71)
Neuroscience (1566)
Neurotech (1)
NextGen: Class of 2026 (2430)
Non-profit (1001)
Now hiring (45)
Obesity (520)
Opinion (233)
Ovarian cancer (66)
Pain (149)
Pancreatic cancer (97)
Parkinson's disease (156)
Partnered (18)
Patents (280)
Patient recruitment (245)
Peanut (19)
People (34885)
Pharmaceutical (76)
Pharmacy benefit managers (33)
Phase 1 (14234)
Phase 2 (19051)
Phase 3 (15306)
Pipeline (2934)
Policy (235)
Postmarket research (1622)
Preclinical (4989)
Press Release (29)
Prostate cancer (131)
Psychedelics (27)
Radiopharmaceuticals (183)
Rare diseases (537)
Real estate (3235)
Recruiting (33)
Regulatory (13905)
Reports (25)
Research institute (884)
Resumes & cover letters (141)
Rett syndrome (6)
RNA editing (12)
RSV (44)
Schizophrenia (118)
Series A (119)
Series B (84)
Service/supplier (7)
Sickle cell disease (66)
Special edition (21)
Spinal muscular atrophy (119)
Sponsored (18)
Startups (2062)
State (2)
Stomach cancer (12)
Supply chain (76)
Tariffs (94)
The Weekly (83)
Vaccines (413)
Venture capital (68)
Weight loss (378)
Women's health (40)
Worklife (9)
Date
Today (37)
Last 7 days (268)
Last 30 days (1060)
Last 365 days (15504)
2026 (1527)
2025 (15709)
2024 (17869)
2023 (19886)
2022 (26176)
2021 (26984)
2020 (25206)
2019 (20413)
2018 (15835)
2017 (17413)
2016 (16382)
2015 (19045)
2014 (14977)
2013 (12689)
2012 (13585)
2011 (13950)
2010 (12841)
Location
Africa (425)
Alabama (42)
Alaska (1)
Arizona (93)
Arkansas (8)
Asia (26094)
Australia (3395)
California (4835)
Canada (1831)
China (750)
Colorado (197)
Connecticut (195)
Delaware (180)
Europe (53996)
Florida (838)
Georgia (99)
Hawaii (2)
Idaho (18)
Illinois (446)
India (51)
Indiana (295)
Iowa (5)
Japan (326)
Kansas (84)
Kentucky (29)
Louisiana (7)
Maine (4)
Maryland (599)
Massachusetts (3910)
Michigan (71)
Minnesota (244)
Mississippi (3)
Missouri (43)
Montana (12)
Nebraska (14)
Nevada (35)
New Hampshire (10)
New Jersey (1858)
New Mexico (21)
New York (1340)
North Carolina (795)
North Dakota (2)
Northern California (2262)
Ohio (131)
Oklahoma (8)
Oregon (23)
Pennsylvania (1067)
Puerto Rico (19)
Rhode Island (27)
South America (621)
South Carolina (12)
Southern California (2045)
Tennessee (64)
Texas (661)
United States (18340)
Utah (95)
Virginia (182)
Washington D.C. (60)
Washington State (379)
West Virginia (1)
Wisconsin (49)
Wyoming (1)
349,825 Results for "leo pharma".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
LEO Pharma advances Anzupgo® (delgocitinib) cream to phase 3 trial in lichen sclerosus (LS)
January 21, 2026
·
7 min read
Press Releases
LEO Pharma to Present at the 44th Annual J.P. Morgan Healthcare Conference
January 7, 2026
·
1 min read
Press Releases
LEO Pharma Submits Adolescent Label Expansion Application for Anzupgo® to EMA
December 15, 2025
·
7 min read
Press Releases
LEO Pharma Presents Twenty-Three Posters at Maui Derm Hawaii 2026, Demonstrating Continued Commitment to Scientific Innovation in Medical Dermatology
January 26, 2026
·
19 min read
Press Releases
LEO Pharma Closes Deal for Spevigo®
October 1, 2025
·
6 min read
Press Releases
LEO Pharma Announces Positive Topline 32-Week Key Results in ADHAND Trial
November 17, 2025
·
8 min read
Press Releases
LEO Pharma Strengthens Leadership in Medical Dermatology with the Appointment of Sophie Lamle as Chief Development Officer
November 4, 2025
·
2 min read
Press Releases
LEO Pharma Delivers 8% Revenue Growth at CER in 9M 2025 and Updates Full-Year Outlook
November 6, 2025
·
3 min read
Press Releases
LEO Pharma Unveils Data on the U.S. Prevalence of Chronic Hand Eczema at Fall Clinical Dermatology Conference
October 27, 2025
·
7 min read
Press Releases
LEO Pharma continues global rollout of Anzupgo® (delgocitinib) cream with submission of New Drug Application in China
October 17, 2025
·
10 min read
1 of 34,983
Next
